Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Parkinsonism & Related Disorders

205 та иш

Журнал · ISSN 1353-8020

  1. Psychotherapeutic treatment of cognitive impairtment in children with tic hyperkinesis

    D. Sattarova, Y.N. Madjidova, N. Azimova +1

    МақолаObsessive-Compulsive Spectrum DisordersParkinsonism & Related Disorders20180 иқтибос
    ABI

  2. Assessment of the quality of life of patients with Parkinson’s disease with chronic pain syndrome

    A. Umarov, G. Rakhimbaeva

    МақолаParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  3. Antidepressants efficiency in patients with depression and depression related to Parkinson’s disease

    A. Kostyunina, Bekhzod Abdullaev, K. Narkulova

    МақолаParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  4. Clinical features and differential diagnostic criteria of PANDAS syndrome and Sydenham’s chorea

    Iroda Nasirova, Y.N. Madjidova, G.K. Sadikova +2

    МақолаObsessive-Compulsive Spectrum DisordersParkinsonism & Related Disorders20180 иқтибос
    ABI

  5. Conflicts of western and eastern publications regarding spinocerebellar ataxias

    Oybek Turgunkhujaev, N. Tolibova

    МақолаGenetic Neurodegenerative DiseasesParkinsonism & Related Disorders20180 иқтибос
    ABI

  6. The frequency of motor disorders in diabetic encephalopathy

    Aliya Gumarova, Zamira Khalimova, Y.N. Madjidova +2

    МақолаNeurological and metabolic disordersParkinsonism & Related Disorders20180 иқтибос
    ABI

  7. The effectiveness of neurometabolic treatment of Parkinson’s disease (PD) and vascular parkinsonism

    Nodirjon Ruzimurodov, D. Tolibov, D. Mirzaeva

    МақолаNeurological Disorders and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  8. Interrelation of cognitive impairments and quality of life between motor disorders in patients with vascular Parkinsonism

    D. Tolibov, M. Roziqova

    МақолаNeurological Disorders and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  9. Diagnostic markers in the pathogenesis of parkinsonism syndrome development in chronic brain ischemia

    K. Khajibakiev

    МақолаNeurological Disorders and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  10. Characteristic of cognitive disturbances in early stages of Parkinson disease

    N. Ruzimova, R. Azizova

    МақолаNeurological Disorders and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  11. Features of MRI signs of Parkinson’s disease (PD) and vascular parkinsonism

    A. Umarov, G. Rakhimbaeva

    МақолаNeurological disorders and treatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  12. Parkinsonian syndrom prevalence in the world

    I. Akmal, D. Azizova

    МақолаNeurological disorders and treatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  13. Oxotremorine model of tremor

    D. Tursunov

    МақолаNeurological disorders and treatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  14. Synchronicity of climate fluctuation with daily activity of alpha synucleinopathic patients

    Oybek Turgunkhujaev, N. Tolibova

    МақолаClimate Change and Health ImpactsParkinsonism & Related Disorders20180 иқтибос
    ABI

  15. The pathogenesis of vascular parkinsonism

    M. Makhkamova

    МақолаNeurological disorders and treatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  16. Comparative analysis of sleep disorders between groups of patients with Parkinson’s disease and Parkinson’s syndrome

    Sojida Djalilova

    МақолаSleep and related disordersParkinsonism & Related Disorders20180 иқтибос
    ABI

  17. Rotenone model of Parkinson’s syndrome

    D. Kodirova

    МақолаElectron Spin Resonance StudiesParkinsonism & Related Disorders20180 иқтибос
    ABI

  18. Recommendation for modeling of parkinsonian syndrome

    D. Safarbekov, D. Tursunov

    МақолаParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  19. The importance of apoproteins in the development of Parkinson’s disease

    A. Dilzoda

    МақолаParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  20. The role of the endothelial growth factor (EGF) in Parkinson disease

    S Fakhargalieva, R. Azizova

    МақолаCerebrovascular and genetic disordersParkinsonism & Related Disorders20180 иқтибос
    ABI

  21. Motor and cognitive impairment in patients with Parkinson’s disease who underwent ischemic stroke

    M. Mukhamedkhanova, Y.N. Madjidova, Mukhlisa Khanova

    МақолаNeurological Disorders and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  22. Some movement disorders as diagnostic predictions of Juvenile chorea

    M. Sanoyeva

    МақолаBotulinum Toxin and Related Neurological DisordersParkinsonism & Related Disorders20180 иқтибос
    ABI

  23. Correlation analysis between cholinergic system and vegetative status in Parkinson disease

    R. Azizova, Mujaahida Shakur

    МақолаCholinesterase and Neurodegenerative DiseasesParkinsonism & Related Disorders20180 иқтибос
    ABI

  24. Non-motor predictors of early manifestations of Parkinson’s disease

    R. Azizova, Mujaahida Shakur

    МақолаParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI

  25. Features of cognitive functions of Parkinson’s disease (PD) and vascular parkinsonism

    D. Tolibov, G. Rakhimbaeva

    МақолаNeurological Disorders and TreatmentsParkinsonism & Related Disorders20180 иқтибос
    ABI